Navigation Links
HIVMA opposes The Gambia's unproven AIDS remedy

Leading HIV experts are alarmed that the government of The Gambia is encouraging citizens living with HIV to stop taking antiretroviral medications in order to try an unproven herbal remedy. The HIV Medicine Association (HIVMA) calls on President Yahya Jammeh to cease his unproven claims that the treatment "cures" AIDS.

Earlier this year, President Jammeh began applying his treatment to a handful of patients who had been doing well on antiretroviral therapy but stopped taking the drugs in order to qualify to receive his "cure."

HIVMA joins its colleagues in the International AIDS Society and the Society for AIDS in Africa in expressing great concern regarding this practice. "There currently is no cure for HIV/AIDS," said HIVMA Chair Daniel R. Kuritzkes, MD. "President Jammeh is giving people false hope, while at the same time making them stop treatment that has been demonstrated to save lives."

"Any treatment that claims to alleviate this devastating disease must be subjected to rigorous scientific scrutiny," he added. "A growing body of evidence from Africa shows the lifesaving effects of antiretroviral medicines for people living with HIV/AIDS. On the other hand, the remedy President Jammeh is promoting is untested. It is highly unethical to stop a proven therapy to try an unproven one. We are extremely concerned that President Jammeh would recklessly experiment with his people’s lives."

"We support the tireless efforts of African scientists, clinicians, and community health workers providing antiretroviral treatment to communities that are so deeply affected by this disease." Dr. Kuritzkes added. "We urge the government of the Gambia to support their efforts as well."

Dr. Kuritzkes concluded, "People around the world living with HIV/AIDS deserve safe, effective, and affordable treatment, regardless of the source. If President Jammeh’s remedy is as effective as he claims, it will stand up to examination. In the mean time, we urge patients receiving his unproven herbal remedy to resume taking their antiretroviral medications, which have a well-established track record of saving lives in Africa."
'"/>

Source:Infectious Diseases Society of America


Related biology news :

1. Insight into natural cholesterol control suggests novel cholesterol-lowering therapy
2. Medical whistleblowers speak out
3. The evolutionary triumph of flower power
4. Bumblebees copy one another when contending with unfamiliar flowers
5. Analysis of flower genes reveals the fate of an ancient gene duplication
6. Gene therapy to lower blood pressure just enough
7. Long-sought flower-inducing molecule found
8. Divergent mating systems and parental conflict as a barrier to hybridization in flowering plants
9. Reducing antibiotic use lowers rates of drug-resistant bacteria
10. Recreating Flowers for Algernon with a happy ending
11. Overfishing may drive endangered seabird to rely upon lower quality food

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/2/2017)... , March 2, 2017 Who risk to ... Download the full report: https://www.reportbuyer.com/product/4313699/ ... FINGERPRINT SENSOR FIELD? Fingerprint sensors using capacitive technology ... fingerprint sensor vendor Idex forecasts an increase of 360% ... devices and of the fingerprint sensor market between 2014 ...
(Date:2/28/2017)... ANGELES , Feb. 28, 2017   Acuant ... verification software globally, announces significant enhancements to new and ... May 2016. New products include mobile and desktop Acuant ... DocX TM - a real time manual review ... core idScan® technology provides the fastest and most accurate ...
(Date:2/27/2017)... 2017   Strategic Cyber Ventures , the industry,s ... a $3.5 million investment in  Polarity , the first ... is DC based and is led by cybersecurity veterans ... Ron Gula , also a longtime cybersecurity veteran ... this series A round of funding. This new funding ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... , March 22, 2017 Oramed ... ( www.oramed.com ), a ... oral drug delivery systems, announced today that Dr. ... will deliver a presentation titled, "Oral Insulin for ... Cambridge Healthtech Institute,s Oligonucleotide and Peptide Therapeutics (OPT) ...
(Date:3/22/2017)... New York , March 22, 2017 ... is largely fragmented, states a research report by Transparency ... S.A., Pfizer Inc., Amgen Inc., and AbbVie Inc., accounted ... in 2015. The prominent players in this market are ... expand their product portfolio, which is likely to lead ...
(Date:3/22/2017)... , March 22, 2017 /PRNewswire/ - FACIT announced ... "Company" or "Propellon"), a start-up created by FACIT ... therapeutics. FACIT,s investment, combined with non-dilutive capital, achieves ... The seed funding enables Propellon to accelerate the ... Company for financing and/or entering a strategic partnership ...
(Date:3/22/2017)... 22, 2017   VWR (NASDAQ: ... product and service solutions to laboratory and ... acquired EPL Archives, Inc., an international biorepository ... entire regulated product research, development and commercialization ... and ancillary services. EPL Archives is widely ...
Breaking Biology Technology: